APA

Moura F. A., Figueiredo V. N., Teles B. S. B. S., Barbosa M. A., Pereira L. R., Costa A. P. R., Carvalho L. S. F., Cintra R. M. R., Almeida O. L. R., Quinaglia E Silva J. C., Nadruz Junior W. & Sposito A. C. (20160914). Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients. : Atherosclerosis.

Chicago

Moura Filipe A, Figueiredo Valeria N, Teles Bruna S B S, Barbosa Meyrianne A, Pereira Lara R, Costa Ana P R, Carvalho Luiz Sergio F, Cintra Riobaldo M R, Almeida Osório L R, Quinaglia E Silva Jose C, Nadruz Junior Wilson and Sposito Andrei C. 20160914. Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients. : Atherosclerosis.

Harvard

Moura F. A., Figueiredo V. N., Teles B. S. B. S., Barbosa M. A., Pereira L. R., Costa A. P. R., Carvalho L. S. F., Cintra R. M. R., Almeida O. L. R., Quinaglia E Silva J. C., Nadruz Junior W. and Sposito A. C. (20160914). Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients. : Atherosclerosis.

MLA

Moura Filipe A, Figueiredo Valeria N, Teles Bruna S B S, Barbosa Meyrianne A, Pereira Lara R, Costa Ana P R, Carvalho Luiz Sergio F, Cintra Riobaldo M R, Almeida Osório L R, Quinaglia E Silva Jose C, Nadruz Junior Wilson and Sposito Andrei C. Glycosylated hemoglobin is associated with decreased endothelial function, high inflammatory response, and adverse clinical outcome in non-diabetic STEMI patients. : Atherosclerosis. 20160914.